Navigation Links
Inspiration Biopharmaceuticals Announces Filing of IND for Novel Recombinant Factor IX Product, IB1001, for the Treatment of Hemophilia B
Date:11/13/2007

LAGUNA NIGUEL, Calif., Nov. 13 /PRNewswire/ -- Inspiration Biopharmaceuticals announced today that it has filed an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) to begin clinical trials with IB1001, an intravenous recombinant Factor IX (rFIX) product for the on demand and prophylactic treatment of the bleeding disorder associated with hemophilia B.

Upon FDA approval of the IND application, Inspiration Biopharmaceuticals intends to enter Phase 1/2 clinical trials to evaluate the pharmacokinetics (PK) and safety profile of IB1001, compared with the commercially available Factor IX products; rFIX, BeneFix(R) and plasma-derived Factor, MonoNine(R). Following successful completion of the PK phase of this study, patients will then enroll in one of two trials: a six month Phase 1/2 On Demand trial to document safety and efficacy in treating spontaneous bleeding episodes or a pivotal Phase 2/3 Prophylaxis trial to document safety and efficacy in the prevention of spontaneous bleeding. In addition, the safety and efficacy of peri-surgical prophylactic administration of IB1001 to control bleeding during surgical procedures will be evaluated. The rate of inhibitor formation will be evaluated throughout all phases of the clinical investigation of IB1001.

"We are excited to be filing an IND for IB1001," said Michael Griffith, Ph.D., President and CEO, Inspiration Biopharmaceuticals. "Preclinical studies have demonstrated the expected PK and safety profile for IB1001 when compared to the clinically proven commercial Factor IX products. Our cost-effective manufacturing platform for Factor IX positions Inspiration to expand the global supply of i.v. rFIX and to develop next generation products to facilitate prophylactic care of the hemophilia B patients worldwide. Our ultimate goal is to leverage our low cost manufacturing technology to find the means for non-invasive delivery of Factor IX which we believe may represe
'/>"/>

SOURCE Inspiration Biopharmaceuticals
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
2. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
3. Nabi Biopharmaceuticals Announces Continued Positive NicVAX Phase 2b Data at Nine Months
4. Keryx Biopharmaceuticals to Present at William Blair & Company Small-Cap Growth Stock Conference
5. Morria Biopharmaceuticals Plc Initiates Phase I Clinical Study of MRX-4 in Allergic Rhinitis
6. Keryx Biopharmaceuticals, Inc. Announces Positive Preliminary Phase 2 Data on KRX-0401 in Patients with Chemo-Insensitive Rare Sarcoma
7. Nabi Biopharmaceuticals Announces Successful Completion of NicVAX(R) Phase 2b Trial; Drug Shows Statistically Significant Rates of Smoking Cessation and Continuous Long-Term Smoking Abstinence at 12 Months
8. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
9. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
10. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
11. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... , Jan. 14, 2014 InformEx, North America,s ... of high-value chemistry, will hold the 30 th edition ... Convention Center from January 21-24. (Logo: ... from top pharmaceutical, fine chemical and specialty chemical companies will ...
(Date:1/14/2014)... 14, 2014 Animal Emergency Critical Care, a LifeCentre partner practice, ... is the first in Loudoun County ... Dr. Susan M. Barnes , Medical Director, is a ... Dr. Cole Taylor , are avid scuba divers. "As altitude ...
(Date:1/14/2014)... , January 14, 2014 ... Transfer Devices (CSTD) for hazardous drugs, today announced that it ... fourth straight year.   Equashield,s closed ... technicians, pharmacists, nurses and other medical professionals who ...
Breaking Medicine Technology:Media Advisory: InformEx 2014 Events & Speaker Lineup for 30th Edition Conference in Miami Beach 2Hyperbaric Veterinary Medicine (hvm) Announces Animal Emergency Critical Care Installs A Small Animal Hyperbaric Chamber 2Equashield's Sales Grow by 60% in 2013 2
... Calif., Dec. 7, 2011 Rigel Pharmaceuticals, Inc. (Nasdaq: ... the company,s president and chief operating officer, is scheduled ... Annual Healthcare Conference in New York City on Wednesday, ... (Logo: http://photos.prnewswire.com/prnh/20030226/RIGLLOGO ) To ...
... 7, 2011   Talyst has released an updated ... The bar code technology ensures virtually 100% of medications ... The improved AutoLabel is a complete ... and white transfer labels to improve patient safety at ...
Cached Medicine Technology:Talyst Updates Its AutoLabel® Solution 2
(Date:4/23/2014)... The American Gastroenterological Association (AGA) Research Foundation ... Scholars. The AGA Research Scholar Awards program, launched ... and productive research careers in digestive diseases. This ... additional year allowing for three consecutive years of ... faculty who are paving the way for promising ...
(Date:4/23/2014)... led by a researcher from the Cancer Science Institute ... Singapore has identified the cancer specific stem cell which ... of developing new drugs for the treatment of this ... group, led by Dr Chan Shing Leng, Research Assistant ... that a cancer-specific variant of a cell surface protein, ...
(Date:4/23/2014)... Previous studies have shown that proliferation of endogenous ... damage to neurons and axons. From the perspective ... from Sun Yat-sen University in China observed the ... neural precursor cell proliferation and expression of basic ... the rat brain on the infarct side. The ...
(Date:4/22/2014)... Over the last few decades researchers have characterized a ... physiology and behavior in all types of species, from ... been identified, but researchers surmise there are more. A ... University of Pennsylvania wondered if big-data approaches could find ... led by John Hogenesch, PhD, professor of Pharmacology and ...
(Date:4/22/2014)... April 22, 2014: The Association for Molecular Pathology ... Journal of Molecular Diagnostics on recommendations for ... and master,s levels of education. The report was ... Task Force of the AMP Training and Education ... need of educating future medical laboratory scientists appropriately ...
Breaking Medicine News(10 mins):Health News:AGA announces 2014 Class of AGA Research Scholars 2Health News:Scientists identify cancer specific cell for potential treatment of gastric cancer 2Health News:Scientists identify cancer specific cell for potential treatment of gastric cancer 3Health News:Bioinformatics profiling identifies a new mammalian clock gene 2Health News:AMP publishes curriculum recommendations for medical laboratory scientists 2
... , ... ago to help her lose weight after the birth of her last child. At just ... valves were so severely damaged because of the diet drug. , ... Pocatello, ID (PRWEB) April 8, 2010 -- Pocatello resident Cindy Cartwright knows ...
... , ... HyGreen™ has been recognized in the 2010 Medical Design Excellence Awards competition, one of ... ... Xhale Innovations’ HyGreen™ has been recognized in the 2010 Medical Design Excellence ...
... ... the clamorous demand for greater social and environmental accountability and meet the UN-set goal ... their concerns and showcase their successes. , ... (PRWEB) April 8, 2010 -- A major national conference on ...
... Acclaimed workforce ... , ... -- As budget-conscious companies look for creative ways to reduce employee turnover, cut back on ... growing trend. Billed as a progressive workplace benefit, PRtW is designed to smooth the transition ...
... with an increased risk of stroke in middle-aged and ... a landmark study supported by the National Heart, Lung, ... Health. Overall, sleep apnea more than doubles the risk ... common disorder in which the upper airway is intermittently ...
... ... ... During the month of April, AthletiCo Physical Therapy and Occupational Therapy celebrates ... occupational/hand therapists are the premier specialists in treating upper extremity diagnoses. , , ...
Cached Medicine News:Health News:Triple Heart Valve Replacement Saves Local Women's Life at Portneuf Medical Center: Woman Gets a Second Chance at Life After Taking Fen-Phen 2Health News:ROBRADY Design's Work with Xhale Innovations Inc. Wins 2010 Medical Design Excellence Awards 2Health News:ROBRADY Design's Work with Xhale Innovations Inc. Wins 2010 Medical Design Excellence Awards 3Health News:Reducing Energy Consumption Dramatically: Green IT Conference Addresses Administration's Goals 2Health News:Intellicate Announces New “Phased Return to Work” (PRtW) Service 2Health News:Intellicate Announces New “Phased Return to Work” (PRtW) Service 3Health News:Sleep apnea tied to increased risk of stroke 2Health News:Sleep apnea tied to increased risk of stroke 3Health News:Sleep apnea tied to increased risk of stroke 4Health News:AthletiCo Offers Occupational Therapy Tips for Managing Arthritis 2Health News:AthletiCo Offers Occupational Therapy Tips for Managing Arthritis 3
... INSTAT Collagen Absorbable Hemostat is a purified ... prepared as a sponge-like pad, is lightly ... which is an inherent property of collagen, ... structure of this protein. The helical structure ...
... Microspin centrifuge offers reliable microhematocrit determinations. Although ... it is more affordable than most competitive ... assures rapid spin-downs, and the included reader ... variety of circumstances. Offering quieter operation than ...
... international engineering and design specifications, Smith ... System* provides seamless integration with existing ... open reduction internal fixational procedures (AO ... well beyond the standard, providing a ...
... of the most technically demanding specialties within ... offers the highly specialized surgeon a complete ... the pelvis and acetabulum. , ,Joel ... pelvic surgeon, is the designer of this ...
Medicine Products: